UCB - Ebitda

Stock Price
264.50
Daily Change
-3.30 -1.23%
Monthly
4.59%
Yearly
64.44%
Q2 Forecast
257.81

UCB reported EUR1.6B in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Alcon AG USD 317M 337M Dec/2025
Almirall EUR 114.07M 60.37M Dec/2025
Amarin USD 12.54M 28.57M Jun/2025
argenx SE USD 387.05M 99.02M Sep/2025
AstraZeneca USD 5.23B 272M Sep/2025
Bayer EUR 1.97B 457M Dec/2025
Galapagos EUR 2.42M 161.13M Sep/2025
Genmab DKK 186M 291M Dec/2025
GlaxoSmithKline GBP 3.36B 179M Sep/2025
GRIFOLS EUR 347.24M 58.35M Jun/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Lonza CHF 1.01B 54M Dec/2025
Merck EUR 1.44B 263M Dec/2025
Novartis USD 4.77B 1.11B Dec/2025
Orion EUR 343M 207.9M Dec/2025
Recordati EUR 247.15M 421K Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Sanofi EUR 4.84B 2.95B Sep/2025
UCB EUR 1.6B 570M Dec/2025
Unibail Rodamco EUR 1.02B 71.7M Dec/2024